[A case of unresectable advanced pancreatic tail cancer successfully treated with gemcitabine hydrochloride].
We report a case of a 76-year-old female with unresectable advanced pancreatic tail cancer in whom systemic chemotherapy using gemcitabine hydrochloride was effective. The patient came to our hospital with a complaint of upper abdominal discomfort and was diagnosed as an advanced pancreatic tail cancer with severe vessel invasion. A curative operation was thought to be impossible, so gemcitabine hydrochloride was administered (800 mg/m2/week x 3/4 weeks). After 2 courses, the CEA, CA19-9 and SPan-1 value were decreased, and reduced tumor size was identified. Sixteen months after the first diagnosis, she died dissemination.
Akutsu
Yasunori
Y
Dept. of Surgery, Kumagaya General Hospital.
Endo
Masato
M
Yoshinaga
Yushin
Y
Hoshino
Toshihiko
T
Ota
Yoshihito
Y
Tsunoda
Yozo
Y
Matsubara
Hisahiro
H
Ochiai
Takenori
T
D000368:Aged; D000964:Antimetabolites, Antineoplastic / Q000627:therapeutic use*; D003841:Deoxycytidine / Q000031:analogs & derivatives* / Q000627:therapeutic use*; D004334:Drug Administration Schedule; D005260:Female; D006801:Humans; D009361:Neoplasm Invasiveness; D010190:Pancreatic Neoplasms / Q000098:blood supply / Q000188:drug therapy* / Q000473:pathology; D010534:Peritoneal Neoplasms / Q000473:pathology; D011788:Quality of Life; D000093542:Gemcitabine
D000964:Antimetabolites, Antineoplastic; D003841:Deoxycytidine; D000093542:Gemcitabine